• Home
  • About

    About

    • Profile
    • Honor
    • Development History
  • Product

    Product

      * TB-IGRA * HPV DNA 15/31 Type * Membrane Hybridization Method HPV E6/E7 mRNA Genotype * Respiratory 12/15-item Pathogen Nucleic Acid Detection Kit
    • POCT series
      instrument Inflammatory Marker Cardiac marker Heart failure marker Hormone Gastric function Renal Marker
    • Molecular diagnostic series
    • MPA method
    • STH-PAS method
    • Novel coronavirus (COVID-19) series
    • MORE
  • Solutions

    Solutions

    • Multiplex Probe Amplification
    • Chromatography Membrane Hybridization Method
  • News

    News

    • Biotron news
    • Exhibition
  • Contact us
  • CN
  • Home
  • About
    Profile Honor Development History
  • Product
    POCT series Molecular diagnostic series MPA method STH-PAS method Novel coronavirus (COVID-19) series MORE
  • Solutions
    Multiplex Probe Amplification Chromatography Membrane Hybridization Method
  • News
    Biotron news Exhibition
  • Contact us
  • CN
Index > Product > MPA method

* Respiratory 12/15-item Pathogen Nucleic Acid Detection Kit

Avoid missed tests for multiple infections/combinations multiple/combined infections effective information

Analysis software: realizing automatic interpretation 

The minimum detection limit is not higher than 1000 copies/ml, with high accuracy and specificity. 

Melting curve analysis method: detecting 12  pathogens respectively. 

Fast reaction (5-10 minutes)

DESCRIPTION

Successfully obtained in the EU CE access certification

Passed ISO13485 certification

Respiratory tract infections are divided into upper respiratory tract infections and lower respiratory tract infections. Upper respiratory tract infections mainly manifest as fever, headache, tinnitus, cough, runny nose, nasal congestion, etc., and are dominated by viruses, accounting for 70% to 80%. Lower respiratory tract infections include pneumonia, tracheitis, bronchitis, capillary bronchitis, etc. Usually, lower respiratory tract infections are much more serious than upper respiratory tract infections, and the pathogens are more complex.

Acute upper respiratory infections occur in most people every year, 2 to 4 times per year in adults and in children at a higher rate of 6 to 8 times per year



Clinical significance: 






  • Early Identification

Direct detection of pathogens, shorten pathogen reporting time, improve the pathogen detection rate, and improve detection of mixed infections


  • Precise treatment

Timely and accurate pathogenic results can promote the rational use of antibacterial drugs, facilitate infection control, and improve patient prognosis


  • Conserve medical resources

Optimize the treatment process, shorten hospital stays, and reduce treatment costs, resulting in clinical and economic benefits


  • Epidemic prevention and control

Screening and early warning of respiratory diseases, helping to normalize epidemic prevention and control, reducing the spread of respiratory diseases and infections in groups


SPECIFICATION

HOW CAN WE HELP?
Biotron is committed to quality customer service. If you have any question, please feel free to contact us.
Request

Applicable Instrument

CATALOGS

0 pages

TEST MENU

<
>
<
>
  • Product POCT series Molecular diagnostic series MPA method STH-PAS method Novel coronavirus (COVID-19) series MORE
  • Scientific research Multiplex Probe Amplification Chromatography Membrane Hybridization Method
  • About Profile Honor Development History
  • News Biotron news Exhibition
  • Contact

    address:Room 301& 401, Building C6,No. 11 Kaiyuan Road, Huangpu District, Guangzhou,510530.P.R.China

    tel:020-32077730 32077731

    fax:020-32077729

    Email: overseas@ebiotron.com

友情链接 天极科技
版权所有@2020广州市宝创生物技术有限公司All Rights Resserved 粤ICP备2021003845号
网站地图技术支持: 天极科技
  • 返回顶部